Book
1951, xiv, 522
Book
QJM, ISSN 1460-2725, 2016, Volume 109, Issue 6, pp. 377 - 382
Background: Anaemia is common among patients with heart failure (HF) and is an important prognostic marker. Aim: We sought to determine the prognostic...
MORTALITY | TRIAL | MEDICINE, GENERAL & INTERNAL | ARTERIAL STIFFNESS | DISEASE | IRON | SEX-DIFFERENCES | PREVALENCE | OUTCOMES | HEMOGLOBIN LEVEL | DARBEPOETIN-ALPHA | Heart Failure - complications | Anemia - mortality | Prognosis | Prospective Studies | Humans | Heart Failure - physiopathology | Proportional Hazards Models | Stroke Volume - physiology | Male | Cause of Death | Anemia - physiopathology | Anemia - complications | Female | Aged | Heart Failure - diagnosis | Heart Failure - mortality | Original Papers | Klinisk medicin | Clinical Medicine
MORTALITY | TRIAL | MEDICINE, GENERAL & INTERNAL | ARTERIAL STIFFNESS | DISEASE | IRON | SEX-DIFFERENCES | PREVALENCE | OUTCOMES | HEMOGLOBIN LEVEL | DARBEPOETIN-ALPHA | Heart Failure - complications | Anemia - mortality | Prognosis | Prospective Studies | Humans | Heart Failure - physiopathology | Proportional Hazards Models | Stroke Volume - physiology | Male | Cause of Death | Anemia - physiopathology | Anemia - complications | Female | Aged | Heart Failure - diagnosis | Heart Failure - mortality | Original Papers | Klinisk medicin | Clinical Medicine
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 169, Issue 4, pp. 579 - 586.e3
Background There is a genetic contribution to the risk of ventricular arrhythmias in survivors of acute coronary syndromes (ACS). We wished to explore the role...
Cardiovascular | VENTRICULAR EJECTION FRACTION | COMMON VARIANTS | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | MYOCARDIAL-INFARCTION | NOS1AP LOCUS | SUDDEN CARDIAC DEATH | PROLONGED QTC INTERVAL | RISK | POLYMORPHISM | GENOME-WIDE ASSOCIATION | Arrhythmias, Cardiac - metabolism | Genetic Predisposition to Disease | Prospective Studies | Follow-Up Studies | Humans | Risk Factors | Genotype | Male | Arrhythmias, Cardiac - etiology | Genetic Markers | DNA - genetics | Acute Coronary Syndrome - complications | Acute Coronary Syndrome - metabolism | Electrocardiography | Female | Aged | Polymorphism, Single Nucleotide | Acute Coronary Syndrome - genetics | Arrhythmias, Cardiac - genetics | Coronary heart disease | Genetic markers | Single nucleotide polymorphisms | Studies | Heart rate | Cardiac arrhythmia | Heart attacks | Cardiovascular disease | Statistical methods | Diabetes | Acute coronary syndromes | Patients | Age
Cardiovascular | VENTRICULAR EJECTION FRACTION | COMMON VARIANTS | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | MYOCARDIAL-INFARCTION | NOS1AP LOCUS | SUDDEN CARDIAC DEATH | PROLONGED QTC INTERVAL | RISK | POLYMORPHISM | GENOME-WIDE ASSOCIATION | Arrhythmias, Cardiac - metabolism | Genetic Predisposition to Disease | Prospective Studies | Follow-Up Studies | Humans | Risk Factors | Genotype | Male | Arrhythmias, Cardiac - etiology | Genetic Markers | DNA - genetics | Acute Coronary Syndrome - complications | Acute Coronary Syndrome - metabolism | Electrocardiography | Female | Aged | Polymorphism, Single Nucleotide | Acute Coronary Syndrome - genetics | Arrhythmias, Cardiac - genetics | Coronary heart disease | Genetic markers | Single nucleotide polymorphisms | Studies | Heart rate | Cardiac arrhythmia | Heart attacks | Cardiovascular disease | Statistical methods | Diabetes | Acute coronary syndromes | Patients | Age
Journal Article
Value in Health, ISSN 1098-3015, 10/2018, Volume 21, pp. S31 - S31
Journal Article
Cancer Gene Therapy, ISSN 0929-1903, 11/2014, Volume 21, Issue 11, pp. 457 - 462
Our phase I Hepatic Immunotherapy for Metastases (HITM) trial tested the safety of chimeric antigen receptor-modified T-cell (CART) hepatic artery infusions...
SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | RESECTION | ELEVATED PREOPERATIVE NEUTROPHIL | INTERLEUKIN-6 | PROGNOSTIC VALUE | LYMPHOCYTE RATIO | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | COLORECTAL-CANCER | INFLAMMATION | GENETICS & HEREDITY | RADIOFREQUENCY ABLATION | DISEASE PROGRESSION | Infusions, Intra-Arterial - methods | Interleukin-17 - blood | Neutrophils - cytology | Immunotherapy - methods | Prognosis | Enzyme-Linked Immunosorbent Assay | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Liver Neoplasms - drug therapy | Receptors, Antigen, T-Cell - therapeutic use | Liver Neoplasms - immunology | Male | Lymphocytes - cytology | Blood Cell Count | Biomarkers, Tumor - blood | Interleukin-6 - blood | Hepatic Artery - metabolism | Female | Liver Neoplasms - secondary | Cytokines - blood | Antigens | Care and treatment | Genetic aspects | Liver diseases | Metastasis | Properties | chimeric antigen receptor modified T cells | cytokines | neutrophil-lymphocyte ratio | metastatic hepatic colorectal cancer | immunotherapy
SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | RESECTION | ELEVATED PREOPERATIVE NEUTROPHIL | INTERLEUKIN-6 | PROGNOSTIC VALUE | LYMPHOCYTE RATIO | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | COLORECTAL-CANCER | INFLAMMATION | GENETICS & HEREDITY | RADIOFREQUENCY ABLATION | DISEASE PROGRESSION | Infusions, Intra-Arterial - methods | Interleukin-17 - blood | Neutrophils - cytology | Immunotherapy - methods | Prognosis | Enzyme-Linked Immunosorbent Assay | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Liver Neoplasms - drug therapy | Receptors, Antigen, T-Cell - therapeutic use | Liver Neoplasms - immunology | Male | Lymphocytes - cytology | Blood Cell Count | Biomarkers, Tumor - blood | Interleukin-6 - blood | Hepatic Artery - metabolism | Female | Liver Neoplasms - secondary | Cytokines - blood | Antigens | Care and treatment | Genetic aspects | Liver diseases | Metastasis | Properties | chimeric antigen receptor modified T cells | cytokines | neutrophil-lymphocyte ratio | metastatic hepatic colorectal cancer | immunotherapy
Journal Article
Nuclear Inst. and Methods in Physics Research, A, ISSN 0168-9002, 2002, Volume 489, Issue 1, pp. 178 - 188
A calibration source employing Li (t(1/2)=0.838s) has been developed for use with the Sudbury Neutrino Observatory (SNO). This source creates a spectrum of...
Cherenkov detector | Energy calibration | Sudbury Neutrino Observatory | Gas transport, 8B spectrum | Radioactive source | Event reconstruction | Solar neutrinos | Gas transport | 8B spectrum
Cherenkov detector | Energy calibration | Sudbury Neutrino Observatory | Gas transport, 8B spectrum | Radioactive source | Event reconstruction | Solar neutrinos | Gas transport | 8B spectrum
Journal Article
Science, ISSN 0036-8075, 01/1965, Volume 147, Issue 3654, pp. 140 - 141
Journal Article
1909
Conference Proceeding
10.
Full Text
Toxicological Significance of DNA Adducts: Summary of Discussions with an Expert Panel
Regulatory Toxicology and Pharmacology, ISSN 0273-2300, 08/1996, Volume 24, Issue 1, pp. 9 - 18
A workshop was held to discuss the uses of data on DNA adduct measurement in humans and in experimental systems in vitro and in vivo. The discussions focused...
DNA Damage - drug effects | Risk Assessment | Carcinogens - adverse effects | Humans | DNA Adducts - adverse effects | DNA Repair - genetics | Environmental Exposure | Mutation - genetics | DNA Adducts - metabolism | Diet - standards | Dose-Response Relationship, Drug | Tissue Distribution | Animals | DNA Adducts - analysis | In Vitro Techniques | Genetic research | DNA
DNA Damage - drug effects | Risk Assessment | Carcinogens - adverse effects | Humans | DNA Adducts - adverse effects | DNA Repair - genetics | Environmental Exposure | Mutation - genetics | DNA Adducts - metabolism | Diet - standards | Dose-Response Relationship, Drug | Tissue Distribution | Animals | DNA Adducts - analysis | In Vitro Techniques | Genetic research | DNA
Journal Article
Electrophoresis, ISSN 0173-0835, 1990, Volume 11, Issue 9, pp. 777 - 780
Journal Article
Winter Simulation Conference Proceedings, 1995, 1995, pp. 494 - 501
The Proof Animation 2.1 product family provides our customers with the tools for animating a vast array of applications. There is a version of Proof Animation...
Geometry | Computer languages | Design automation | User interfaces | Animation | Displays | Hardware | Mice | Large-scale systems | Statistics
Geometry | Computer languages | Design automation | User interfaces | Animation | Displays | Hardware | Mice | Large-scale systems | Statistics
Conference Proceeding
Proceedings of 1993 Winter Simulation Conference - (WSC '93), 1993, pp. 172 - 178
The Proof Animation/sup TM/ family of animation software is designed to meet the animation needs for a vast array of applications. This product family runs on...
Geometry | Computer languages | Costs | Software design | Computer architecture | User interfaces | Animation | Software systems | Hardware | Application software
Geometry | Computer languages | Costs | Software design | Computer architecture | User interfaces | Animation | Software systems | Hardware | Application software
Conference Proceeding
Postgraduate Medical Journal, ISSN 0032-5473, 02/1993, Volume 69, Issue 808, pp. 117 - 120
Twenty-eight patients (11 Caucasian, 17 black) whose blood pressure was more than 160/96 mmHg after 4 weeks on placebo added to atenolol 100 mg/day were...
MEDICINE, GENERAL & INTERNAL | CALCIUM-ANTAGONISTS | SERUM-LIPIDS
MEDICINE, GENERAL & INTERNAL | CALCIUM-ANTAGONISTS | SERUM-LIPIDS
Journal Article
Journal of Liquid Chromatography, ISSN 0148-3919, 1989, Volume 12, Issue 13, pp. 2575 - 2585
Journal Article
The Journal of Pediatrics, ISSN 0022-3476, 1982, Volume 101, Issue 3, pp. 458 - 460
PEDIATRICS | Theophylline - therapeutic use | Asthma - physiopathology | Double-Blind Method | Rhinitis, Allergic, Seasonal - complications | Humans | Rhinitis, Allergic, Seasonal - drug therapy | Chlorpheniramine - analogs & derivatives | Male | Histamine H1 Antagonists - therapeutic use | Asthma - complications | Histamine H1 Antagonists - pharmacology | Respiration - drug effects | Adolescent | Adult | Female | Chlorpheniramine - pharmacology | Child
Journal Article
Proceedings of the 26th conference on winter simulation, 12/1994, pp. 509 - 516
The Proof Animation 2.0 family of products is the latest achievement in Wolverine's ongoing commitment to produce innovative animation software. Proof...
Geometry | Computer languages | Navigation | Computer architecture | User interfaces | Animation | Displays | Hardware | Application software | Statistics
Geometry | Computer languages | Navigation | Computer architecture | User interfaces | Animation | Displays | Hardware | Application software | Statistics
Conference Proceeding
Proceedings of the 23rd conference on winter simulation, 12/1991, pp. 90 - 94
Proof Animation is high-quality PC-based animation and presentation software. Proof Animation runs on any 286 or better computer with a math coprocessor, EGA...
Computer displays | Computational modeling | Buildings | Software quality | Computer graphics | Animation | Hardware | Mice | Coprocessors | Packaging machines
Computer displays | Computational modeling | Buildings | Software quality | Computer graphics | Animation | Hardware | Mice | Coprocessors | Packaging machines
Conference Proceeding
20.
DE1594299
12/1974
A thermoplastic polyhydroxy ether adhesive comprises a mixture of from 50 to 97 parts of a thermoplastic polyhydroxy ether of formula -[-D-O-E-O-]n-wherein D...
TRANSPORTING | MISCELLANEOUS APPLICATIONS OF MATERIALS | DYES | USE OF MATERIALS AS ADHESIVES | ORGANIC MACROMOLECULAR COMPOUNDS | THEIR PREPARATION OR CHEMICAL WORKING-UP | LAYERED PRODUCTS | MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVINGCARBON-TO-CARBON UNSATURATED BONDS | COMPOSITIONS OF MACROMOLECULAR COMPOUNDS | ADHESIVES | LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT ORNON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM | PAINTS | ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE | METALLURGY | CHEMISTRY | POLISHES | NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL | NATURAL RESINS | MISCELLANEOUS COMPOSITIONS | PERFORMING OPERATIONS | COMPOSITIONS BASED THEREON
TRANSPORTING | MISCELLANEOUS APPLICATIONS OF MATERIALS | DYES | USE OF MATERIALS AS ADHESIVES | ORGANIC MACROMOLECULAR COMPOUNDS | THEIR PREPARATION OR CHEMICAL WORKING-UP | LAYERED PRODUCTS | MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVINGCARBON-TO-CARBON UNSATURATED BONDS | COMPOSITIONS OF MACROMOLECULAR COMPOUNDS | ADHESIVES | LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT ORNON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM | PAINTS | ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE | METALLURGY | CHEMISTRY | POLISHES | NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL | NATURAL RESINS | MISCELLANEOUS COMPOSITIONS | PERFORMING OPERATIONS | COMPOSITIONS BASED THEREON
Patent
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.